APA (7th ed.) Citation

IA, L., G, T., F, R., & F, S. (2025). Higher target attainment for B-lactam antibiotics in patients with Gram-negative bloodstream infections when four times actual minimum inhibitory concentrations and epidemiological cutoff values are applied compared to clinical breakpoints. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 44(5), 1129. https://doi.org/10.1007/s10096-025-05068-x

Chicago Style (17th ed.) Citation

IA, Lejbman, Torisson G, Resman F, and Sjövall F. "Higher Target Attainment for B-lactam Antibiotics in Patients with Gram-negative Bloodstream Infections When Four Times Actual Minimum Inhibitory Concentrations and Epidemiological Cutoff Values Are Applied Compared to Clinical Breakpoints." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology 44, no. 5 (2025): 1129. https://doi.org/10.1007/s10096-025-05068-x.

MLA (9th ed.) Citation

IA, Lejbman, et al. "Higher Target Attainment for B-lactam Antibiotics in Patients with Gram-negative Bloodstream Infections When Four Times Actual Minimum Inhibitory Concentrations and Epidemiological Cutoff Values Are Applied Compared to Clinical Breakpoints." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, vol. 44, no. 5, 2025, p. 1129, https://doi.org/10.1007/s10096-025-05068-x.